• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
All
Options & Futures
Funds
IPO Subscription
Structured Products
Investment Wiki
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List

Allovir(ALVR.US)

Overview
News
Financials
© 2026 Longbridge|Disclaimer

Event Tracking

Mar8
Allovir released FY2024 Q4 earnings on March 7 (EST), actual revenue 0 USD (forecast 0 USD), actual EPS -3.636 USD (forecast -1.15 USD)
04:00
Allovir released FY2024 annual earnings on March 7 (EST), actual revenue 0 USD (forecast 0 USD), actual EPS -11.7339 USD (forecast -15.6399 USD)
04:00
Mar3
Halper Sadeh LLC's Investigation into AlloVir, Inc.'s Merger
18:57
Nov13
Allovir released FY2024 9 Months Earnings on November 12 (EST) with actual revenue of 0 USD and EPS of -8.1123 USD
04:00
Allovir released FY2024 Q3 earnings on November 12 (EST), actual revenue 0 USD (forecast 0 USD), actual EPS -0.8223 USD (forecast -1.15 USD)
04:00
Nov12
AlloVir Acquires Kalaris Therapeutics to Form New Entity
00:46

Schedules & Filings

Schedules
Filings
Mar19
Ticker Change(EST)

From 03.19 changed to KLRS

Mar7
Earning Release(EST)

FY2024 Q4 Earning Release (USD) Net Income -18.27 M, EPS -3.636

Jan16
Reverse Stock Split(EST)

1-for-23 Reverse Stock Split

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
ANPA
86.850
+258.88%
+62.650
NBY
19.160
+102.54%
+9.700
VLN
2.480
+58.97%
+0.920
GP
1.240
+51.04%
+0.419
ATGL
30.610
+46.96%
+9.781
OPAD
2.190
+44.08%
+0.670
VCIG
0.9601
+41.00%
+0.279
THH
29.470
+36.31%
+7.850
APLX
113.630
+35.44%
+29.730
ZNTL
3.740
+31.69%
+0.900
View More